中文版
Watch Us
WeChat
Sina Blog

Momentum Qixuehe

Shaanxi Momentum Qixuehe Pharmaceutical Co.,Ltd.

Founded in 1998, located in Xianyang,the ancient capital of Traditional Chinese Medicine Culture, Shaanxi Momentum Qixuehe Pharmaceutical Co.,Ltd.is a high-tech enterprise of Traditional Chinese Medicine(TCM) that integrates production,learning,researching and marketing.Momentum has three production bases,covering an area of 352mu,with more than 1000 management,scientific research,quality,production and marketing personnel,with an annual production capacity of 2 billion yuan.The marketing head quarter is located in Tiancheng Building, High-tech Second Road,High-tech Zone,Xi’an City. The sales revenue has been increasing year by year.In the past five years, Momentum has rapidly risen to become a star enterprise of TCM in the domestic pharmaceutical industry.

Momentum always adheres to the enterprise development strategy of "Market network construction as basis, brand construction as core, quality construction as life, cultural construction as pillar, and scientific construction for development."; adheres to the marketing strategy of "culture first, academic guidance, specialized marketing, large variety strategy, multi-mode operation, point breakthrough, and comprehensive development"; adheres to "Safe production, standardized management, improved quality, reduced cost, guaranteed market and cooperative innovation"; taken on the company's mission of "devoting to health and inheriting virtue"; persist in the company's tenet of "providing patients with high-quality TCM medicine, effective treatment plan and healthy service". Momentum continuously tap the potential and value of TCM medicine, dedicate to the revitalization and development of the pharmaceutical industry, carry forward and inherit the TCM culture, let TCM go to the world, let Momentum become one of the strong ones of TCM, and make greater contributions to the cause of human health!  

  • Enterprise Concept
    Culture Concept:
    Honest, Law-abiding and Enterprise.

    Enterprise Development Tenet:
    To provide high-quality Chinese medicine, precise treatment scheme and service for civilians and patients.

    Corporate Vision:
    To be one of the top TCM enterprise。
  • Enterprise Strategy
    Development Strategy:
    Market network construction as basis, brand construction as core, quality construction as life, cultural construction as pillar, and scientific construction for development.
    Marketing Strategy:
    Culture first, academic guidance, specialized marketing, large variety strategy, multi-mode operation, breakthrough in point and all-round development.
    Production Strategy:
    standardize management, safety production, improve quality, reduce cost, ensure market, cooperate and innovate.
  • Corporate Culture
    Culture Concept:
    Honest, Law-abiding and Enterprise.

    Corporate Culture:
    Momentum has always been taking the core thought of Confucianism as the cornerstone, benevolence, righteousness, etiquette, wisdom and trust as the core elements, shaping the enterprise culture of Momentum, and established the Momentum School of industry, through the construction of enterprise culture, improving the self-cultivation of employees and promoting the TCM culture.
Products

Momentum Qixuehe Pharmaceutical Co., Ltd. always adheres to the corporate culture concept of "honest, law-abiding and enterprise", always adheres to the development concept of "being a science and technology-based TCM medicine enterprise, making high-quality TCM medicine", strives to improve the core competitiveness of the enterprise, and creates the brand and business status of the enterprise. In 2014, Momentum pharmaceutical wholly acquired Lijun Qinling National Pharmaceutical and in 2015, wholly merged and reorganized Shaanxi Qilin Pharmaceutical and won the honors of "High-tech Enterprise", "Model Enterprise of pharmaceutical industry in Shaanxi Province" for many consecutive years. In 2018 "Shaanxi province promotes high quality development of private economy" conference, Momentum awarded "100 excellent private enterprises" and "100 excellent private entrepreneurs". ”Momentum was awarded the honorable title of "excellent private enterprise of Shaanxi Province" by the CPC Shaanxi Provincial Committee and Shaanxi Provincial People's government, and won the affirmation and praise of governments and associations at all levels. 

 

On November 5, 2018, "Shaanxi Momentum Qixuehe Pharmaceutical Co., Ltd." and "Moorfield Eye Hospital" Research Foundation reached cooperation, and the formal signing ceremony was successfully held in London, UK.

 

 

Momentum’s five innovative ideas of "scientific research innovation, system innovation, marketing innovation, manufacturing innovation, internet + innovation" drive the rapid development of enterprises. The biggest core competitiveness of Momentum comes from innovation, from the self-confidence and love of Momentum people for the cause of TCM culture, from innovation is the productivity strategy and huge scientific research investment. The company now has 108 approval numbers, 18 exclusive products and 10 exclusive dosage forms; 17 national invention patents; 5 new drug projects under research; the products cover cardio cerebrovascular disease, gynecology, urology, respiratory, digestive, orthopedics, pentalogy, dermatology and etc.Momentum not only has many exclusive varieties, but also has many advantages in strategic products. Its characteristics are as follows: (1) it has great clinical gold value, (2) it has rich technology, (3) it has leading brand potential, (4) it has outstanding advantages in cultivating large varieties, (5) it has large market capacity of single products. Momentum has 9 strategic products that can reach more than 1 billion market sales in the future. Especially in the aspect of scientific research and innovation, in recent years, Momentum have implemented the strategy of large variety cultivation, continuously optimized product quality, excavated the scientific and technological value of TCM, and achieved great scientific research results. Momentum have been in the forefront of the industry, and have been recognized and praised by the industry. For example, our strategic variety "Xinsuning capsule" has been cultivated in large varieties since 2013. In the same year, it was registered internationally. 900 cases and 39 large-scale Chinese and Western medicine hospitals participated in the clinical research in line with international standards. A comparative study of Xinsuning capsule and Western Medicine mexiletine was used as the evidence-based medicine research. The material research was carried out in the Chinese Academy of inspection. In 2014, Momentum and the Department of Science of Oxford University Students in England carried out the research on the mechanism of Xinsuning compound. In 2015, Momentum and Oxford University established the Chinese herbal medicine laboratory, which was received by Vice Premier Liu Yandong and fully affirmed and praised.In 2016, evidence-based medicine research of Xinsuning revealed that Xinsuning was 4 percentage points higher than western medicine mexiletine. The paper topic was to be published on the authoritative international Lancet, winning honor for TCM in the field of international high-end magazines. In December 2016, Xinsuning won the Industrial Award nomination approved by the State Council in the Great Hall of the people. The award was presented by Gu Xiulian, the former Vice Chairman of the State Council. In 2017, Momentum and Oxford University jointly applied for an international patent for the research results of Xinsuning. Previous studies showed that Xinsuning capsule significantly prolonged the action potential interval of cardiac myocytes. The mechanism of action was similar to that of amiodarone, a famous western medicine, but there was no side effect as amiodarone. Due to the outstanding achievements of Xin Su Ning in the electrophysiologic study of University of Oxford, in December 2017, Oxford decided to upgrade the Chinese Herbal Medicine Laboratory to the Oxford University Research Center of Traditional Chinese Medicine. As the innovation point of The Belt and Road of Chairman Xi Jinping, in December 2018 Xinsuning was included in the 10 major Chinese medicine varieties in 13th Five-Year by the Ministry of science and technology. This is the honor of Momentum people, Xianyang people and the people of Western Shaanxi. The future research goal of Xinsuning capsule is must enter the FDA research in the United States and go to the world! 

Dedication and Inheritance
        

In terms of marketing innovation, Momentum vigorously carried out academic marketing, cooperated with the Committee of Appropriate Health Technology of Traditional Chinese Medicine, guided by the spirit of TCM Law and the document of Strategic Planning Outline of TCM Development (2016-2030), and jointly initiated the "Benevolence Medical Project" with the Committee of Appropriate Health Technology of Traditional Chinese Medicine. The project has established a national multi-level training system for basic level doctors with appropriate health technology, i.e. primary class at county level - primary class at provincial level - middle and senior class at provincial level - senior class in Beijing - Benevolence Medical Project Forum - Oxford University in UK. We have successively cooperated with Shaanxi University of TCM, Henan University of TCM, Nanjing University of TCM, Shandong University of TCM, Hebei College of TCM and Hunan University of TCM. Fujian University of TCM and China Academy of TCM set up a training base for doctors at the grass-roots level. Advanced training courses are held every 45 days.International exchanges on appropriate health technologies of TCM are held once or twice a year. We have carried out three times in the United Kingdom, one in the United States. We have set up a base for doctors at the grass-roots level in five provinces. We hold Bo’ao International Forum for thousands of people every year in the last four years, after four years of unremitting efforts, "Benevolence Medical Project" has formed a brand in the industry, and has truly become a platform for the skills, learning, communication and growth of grassroots doctors of traditional Chinese medicine. In recent years, the "benevolence Medical Project" has trained tens of thousands of grassroots doctors, and really improved the medical skills of grassroots doctors. Many grassroots doctors have become local famous doctors, benefiting one side of the people, effectively alleviating the difficulty and expensive problem of grassroots people's medical treatment, and greatly curbing the abuse of antibiotic infusion. At the same time, it also promotes the development of appropriate health technology of Traditional Chinese Medicine, inherits the culture of TCM, especially the international exchange of TCM, and takes a key step for the rejuvenation of TCM and the realization of the national strategy of going global of TCM. As a Chinese medicine person, we are proud and proud.

Momentum has been strengthening the construction of corporate culture and building a harmonious labor relations. Momentum has always been taking the core thought of Confucianism as the cornerstone, benevolence, righteousness, etiquette, wisdom and trust as the core elements, shaping the enterprise culture of Momentum, and established the Momentum School of industry, through the construction of enterprise culture, improving the self-cultivation of employees and promoting the TCM culture.

Since establishment, Momentum has signed a standard Labor Contract with new employees in time. No matter how much capital pressure there is in the company's development process, economic layoffs have never been adopted. In the context of the whole social and economic downturn, a number of disabled people, laid-off workers, rural surplus labor and veterans have been resettled. At present, 100% of the company's employees have signed labor contracts and paid five insurances and one fund on time, realizing a harmonious labor relations of "no labor dispute, no labor arbitration, no labor dispute".

In recent years, "social responsibility and good corporate image" of Momentum has been recognized by more and more business people. Momentum Qixuehe Pharmaceutical industry will continue to focus on the main theme of the development of the national pharmaceutical industry, actively implement the national development strategy of TCM, and focus on the three core businesses of pharmaceutical production, pharmaceutical research and development, and pharmaceutical sales, to forge a national brand image through innovation and progress and practice corporate social responsibility.

At the 19th national people's Congress, General Secretary Xi has pointed out the direction for our Healthy China Strategy. The development of TCM is ushering in a golden opportunity. We will resonate with the national strategy and continue to shoulder the social responsibility. We will continue to support the public welfare undertakings in a new spirit and keep pace with the national "one belt and one way" strategy to revitalize the national pharmaceutical industry. In the next 5 to 10 years, we will focus on refocusing, do a good job in value marketing, smart marketing and brand marketing, make every effort to create 9 strategic products with a sales value of more than 1 billion yuan, and strive to improve 5 strategic varieties to become leading brands in the industry, so as to realize the dream of 10 billion yuan of enterprise output value of Momentum people, and continue to work with like-minded friends for the country, the society, the pharmaceutical industry and The whole human health cause makes greater contribution! 

Site Home
TOP